I shot through a question to Matt on whether they are still optimistic about IV delivery in the Vaxinia trial which will hopefully get answered in todays online seminar.
I suspect, as you say, the new partnership is just exploring a new way to enhance delivery for particularly difficult to access tumors but it would be nice to hear LC or YF's take on it.
Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration, page-139
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.001(1.02%) |
Mkt cap ! $360.7M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $299.7K | 6.147M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 77 | 9292854 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2346467 | 31 |
View Market Depth
| Last trade - 13.57pm 09/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |